LitCovid-sample-Enju  

PMC:7253482 / 1799-2250 JSONTXT 17 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T272 6-14 NN denotes syndrome
T273 15-26 NN denotes coronavirus
T274 27-28 -LRB- denotes (
T275 28-36 NN denotes MERS-CoV
T276 36-37 -RRB- denotes )
T277 38-40 IN denotes in
T278 41-46 CD denotes 20123
T279 46-47 -COMMA- denotes ,
T280 48-51 CC denotes and
T281 52-56 RBS denotes most
T282 57-65 RB denotes recently
T283 66-68 IN denotes of
T284 69-80 NN denotes SARS-CoV-24
T285 82-87 VBN denotes Given
T286 88-93 PRP-DOLLAR- denotes their
T287 94-103 NN denotes mortality
T288 104-109 NNS denotes rates
T289 109-110 -COMMA- denotes ,
T290 111-114 DT denotes the
T291 115-122 JJ denotes current
T292 123-127 NN denotes lack
T293 128-130 IN denotes of
T294 131-139 VBN denotes targeted
T295 140-150 NNS denotes treatments
T296 151-154 CC denotes and
T297 155-163 JJ denotes licensed
T298 164-172 NNS denotes vaccines
T299 172-173 -COMMA- denotes ,
T300 174-177 CC denotes and
T301 178-183 PRP-DOLLAR- denotes their
T302 184-192 NN denotes capacity
T303 193-195 TO denotes to
T304 196-204 VB denotes transmit
T305 205-212 IN denotes between
T306 213-219 NNS denotes humans
T307 220-223 CC denotes and
T308 224-230 IN denotes across
T309 231-238 NNS denotes species
T310 239-250 NN denotes barriers5,6
T311 250-251 -COMMA- denotes ,
T312 252-257 EX denotes there
T313 258-260 VBZ denotes is
T314 261-263 DT denotes an
T315 264-270 JJ denotes urgent
T316 271-275 NN denotes need
T317 276-279 IN denotes for
T318 280-289 JJ denotes effective
T319 290-305 NNS denotes countermeasures
T320 306-308 TO denotes to
T321 309-315 VB denotes combat
T322 316-321 DT denotes these
T323 322-331 NNS denotes pathogens
T324 333-340 VBG denotes Ongoing
T325 341-348 NN denotes vaccine
T326 349-360 NN denotes development
T327 361-368 NNS denotes efforts
T328 369-374 NN denotes focus
T329 375-377 IN denotes on
T330 378-381 DT denotes the
T331 382-387 NN denotes spike
T332 388-389 -LRB- denotes (
T333 389-390 NN denotes S
T334 390-391 -RRB- denotes )
T335 392-400 NNS denotes proteins
T336 401-405 WDT denotes that
T337 406-414 VBP denotes protrude
T338 415-419 IN denotes from
T339 420-423 DT denotes the
T340 424-429 JJ denotes viral
T341 430-438 NN denotes envelope
T342 439-442 CC denotes and
R267 T273 T272 arg1Of coronavirus,syndrome
R268 T273 T274 arg1Of coronavirus,(
R269 T275 T274 arg2Of MERS-CoV,(
R270 T276 T274 arg3Of ),(
R271 T273 T277 arg1Of coronavirus,in
R272 T278 T277 arg2Of 20123,in
R273 T280 T279 arg1Of and,","
R274 T277 T280 arg1Of in,and
R275 T283 T280 arg2Of of,and
R276 T282 T281 arg1Of recently,most
R277 T283 T282 arg1Of of,recently
R278 T273 T283 arg1Of coronavirus,of
R279 T284 T283 arg2Of SARS-CoV-24,of
R280 T313 T285 arg1Of is,Given
R281 T300 T285 arg2Of and,Given
R282 T288 T286 arg1Of rates,their
R283 T288 T287 arg1Of rates,mortality
R284 T288 T289 arg1Of rates,","
R285 T292 T289 arg2Of lack,","
R286 T292 T290 arg1Of lack,the
R287 T292 T291 arg1Of lack,current
R288 T292 T293 arg1Of lack,of
R289 T296 T293 arg2Of and,of
R290 T295 T294 arg2Of treatments,targeted
R291 T295 T296 arg1Of treatments,and
R292 T298 T296 arg2Of vaccines,and
R293 T298 T297 arg1Of vaccines,licensed
R294 T300 T299 arg1Of and,","
R295 T289 T300 arg1Of ",",and
R296 T302 T300 arg2Of capacity,and
R297 T302 T301 arg1Of capacity,their
R298 T304 T303 arg1Of transmit,to
R299 T302 T303 modOf capacity,to
R300 T304 T305 arg1Of transmit,between
R301 T306 T305 arg2Of humans,between
R302 T285 T307 arg1Of Given,and
R303 T308 T307 arg2Of across,and
R304 T313 T308 arg1Of is,across
R305 T310 T308 arg2Of "barriers5,6",across
R306 T310 T309 arg1Of "barriers5,6",species
R307 T313 T311 arg1Of is,","
R308 T312 T313 arg1Of there,is
R309 T316 T313 arg2Of need,is
R310 T316 T314 arg1Of need,an
R311 T316 T315 arg1Of need,urgent
R312 T316 T317 arg1Of need,for
R313 T319 T317 arg2Of countermeasures,for
R314 T321 T317 arg3Of combat,for
R315 T319 T318 arg1Of countermeasures,effective
R316 T321 T320 arg1Of combat,to
R317 T319 T321 arg1Of countermeasures,combat
R318 T323 T321 arg2Of pathogens,combat
R319 T323 T322 arg1Of pathogens,these
R320 T328 T324 arg1Of focus,Ongoing
R321 T328 T325 arg1Of focus,vaccine
R322 T328 T326 arg1Of focus,development
R323 T328 T327 arg1Of focus,efforts
R324 T328 T329 arg1Of focus,on
R325 T335 T329 arg2Of proteins,on
R326 T335 T330 arg1Of proteins,the
R327 T335 T331 arg1Of proteins,spike
R328 T335 T332 arg1Of proteins,(
R329 T333 T332 arg2Of S,(
R330 T334 T332 arg3Of ),(
R331 T335 T336 arg1Of proteins,that
R332 T335 T337 arg1Of proteins,protrude
R333 T337 T338 arg1Of protrude,from
R334 T341 T338 arg2Of envelope,from
R335 T341 T339 arg1Of envelope,the
R336 T341 T340 arg1Of envelope,viral
R337 T337 T342 arg1Of protrude,and